Nukkleus Inc. (NASDAQ:NUKK) Short Interest Update

Nukkleus Inc. (NASDAQ:NUKKGet Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 190,000 shares, an increase of 490.1% from the December 31st total of 32,200 shares. Based on an average daily trading volume, of 4,280,000 shares, the short-interest ratio is presently 0.0 days.

Nukkleus Stock Performance

NUKK stock traded down $1.35 during trading on Tuesday, hitting $27.32. The company had a trading volume of 243,049 shares, compared to its average volume of 1,814,938. The firm has a 50-day moving average price of $18.64 and a 200-day moving average price of $8.10. Nukkleus has a 12 month low of $1.30 and a 12 month high of $78.32.

Insider Buying and Selling at Nukkleus

In other Nukkleus news, CEO Anastasiia Kotaieva acquired 319,952 shares of the business’s stock in a transaction on Friday, November 8th. The stock was purchased at an average price of $2.41 per share, for a total transaction of $771,084.32. Following the transaction, the chief executive officer now owns 319,952 shares in the company, valued at $771,084.32. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 14.90% of the company’s stock.

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.

Further Reading

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.